Cargando…
The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells
Acute myeloid leukemia (AML) has a high mortality rate despite chemotherapy and transplantation. Both CXCR4/SDF-1 and VLA-4/VCAM1 axes are involved in leukemia protection but little is known about the role of CCL2/CCR2 in AML biology and protection against chemotherapy. We measured CCR2 expression i...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207636/ https://www.ncbi.nlm.nih.gov/pubmed/28045930 http://dx.doi.org/10.1371/journal.pone.0168888 |
_version_ | 1782490402896478208 |
---|---|
author | Macanas-Pirard, Patricia Quezada, Thomas Navarrete, Leonardo Broekhuizen, Richard Leisewitz, Andrea Nervi, Bruno Ramírez, Pablo A. |
author_facet | Macanas-Pirard, Patricia Quezada, Thomas Navarrete, Leonardo Broekhuizen, Richard Leisewitz, Andrea Nervi, Bruno Ramírez, Pablo A. |
author_sort | Macanas-Pirard, Patricia |
collection | PubMed |
description | Acute myeloid leukemia (AML) has a high mortality rate despite chemotherapy and transplantation. Both CXCR4/SDF-1 and VLA-4/VCAM1 axes are involved in leukemia protection but little is known about the role of CCL2/CCR2 in AML biology and protection against chemotherapy. We measured CCR2 expression in AML cell lines and primary AML cells by flow cytometry (FCM), real time PCR (RT-PCR) and western blot (WB). CCL2 production was quantified by solid phase ELISA in peripheral blood (PB) and bone marrow (BM) serum. We measured chemotaxis in a transwell system with different concentrations of CCL2/CCR2 blockers; cell cycle with BrDU and propidium iodide and proliferation with yellow tetrazolium MTT. We determined synergy in in vitro cell apoptosis combining chemotherapy and CCL2/CCR2 blockade. Finally, we performed chemoprotection studies in an in vivo mouse model. Of 35 patients, 23 (65%) expressed CCR2 by FCM in PB. Two cell lines expressed high levels of CCR2 (THP-1 and murine AML). RT-PCR and WB confirmed CCR2 production. CCL2 solid phase ELISA showed significantly lower levels of CCL2 in PB and BM compared to normal controls. Chemotaxis experiments confirmed a dose-dependent migration in AML primary cells expressing CCR2 and THP-1 cells. A significant inhibition of transmigration was seen after CCL2/CCR2 blockade. Proliferation of CCR2+ AML cell lines was slightly increased (1.4-fold) after axis stimulation. We observed a non-significant increase in phase S THP-1 cells exposed to CCL2 and a concomitant decrease of cells in G1. The chemotherapy studies did not show a protective effect of CCL2 on cytarabine-induced apoptosis or synergy with chemotherapy after CCL2/CCR2 blockade both in vitro and in vivo. In conclusion, CCL2/CCR2 axis is expressed in the majority of monocytoid AML blasts. The axis is involved in cell trafficking and proliferation but no in vitro and in vivo chemotherapy protective effect was seen. |
format | Online Article Text |
id | pubmed-5207636 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-52076362017-01-19 The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells Macanas-Pirard, Patricia Quezada, Thomas Navarrete, Leonardo Broekhuizen, Richard Leisewitz, Andrea Nervi, Bruno Ramírez, Pablo A. PLoS One Research Article Acute myeloid leukemia (AML) has a high mortality rate despite chemotherapy and transplantation. Both CXCR4/SDF-1 and VLA-4/VCAM1 axes are involved in leukemia protection but little is known about the role of CCL2/CCR2 in AML biology and protection against chemotherapy. We measured CCR2 expression in AML cell lines and primary AML cells by flow cytometry (FCM), real time PCR (RT-PCR) and western blot (WB). CCL2 production was quantified by solid phase ELISA in peripheral blood (PB) and bone marrow (BM) serum. We measured chemotaxis in a transwell system with different concentrations of CCL2/CCR2 blockers; cell cycle with BrDU and propidium iodide and proliferation with yellow tetrazolium MTT. We determined synergy in in vitro cell apoptosis combining chemotherapy and CCL2/CCR2 blockade. Finally, we performed chemoprotection studies in an in vivo mouse model. Of 35 patients, 23 (65%) expressed CCR2 by FCM in PB. Two cell lines expressed high levels of CCR2 (THP-1 and murine AML). RT-PCR and WB confirmed CCR2 production. CCL2 solid phase ELISA showed significantly lower levels of CCL2 in PB and BM compared to normal controls. Chemotaxis experiments confirmed a dose-dependent migration in AML primary cells expressing CCR2 and THP-1 cells. A significant inhibition of transmigration was seen after CCL2/CCR2 blockade. Proliferation of CCR2+ AML cell lines was slightly increased (1.4-fold) after axis stimulation. We observed a non-significant increase in phase S THP-1 cells exposed to CCL2 and a concomitant decrease of cells in G1. The chemotherapy studies did not show a protective effect of CCL2 on cytarabine-induced apoptosis or synergy with chemotherapy after CCL2/CCR2 blockade both in vitro and in vivo. In conclusion, CCL2/CCR2 axis is expressed in the majority of monocytoid AML blasts. The axis is involved in cell trafficking and proliferation but no in vitro and in vivo chemotherapy protective effect was seen. Public Library of Science 2017-01-03 /pmc/articles/PMC5207636/ /pubmed/28045930 http://dx.doi.org/10.1371/journal.pone.0168888 Text en © 2017 Macanas-Pirard et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Macanas-Pirard, Patricia Quezada, Thomas Navarrete, Leonardo Broekhuizen, Richard Leisewitz, Andrea Nervi, Bruno Ramírez, Pablo A. The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells |
title | The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells |
title_full | The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells |
title_fullStr | The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells |
title_full_unstemmed | The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells |
title_short | The CCL2/CCR2 Axis Affects Transmigration and Proliferation but Not Resistance to Chemotherapy of Acute Myeloid Leukemia Cells |
title_sort | ccl2/ccr2 axis affects transmigration and proliferation but not resistance to chemotherapy of acute myeloid leukemia cells |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5207636/ https://www.ncbi.nlm.nih.gov/pubmed/28045930 http://dx.doi.org/10.1371/journal.pone.0168888 |
work_keys_str_mv | AT macanaspirardpatricia theccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells AT quezadathomas theccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells AT navarreteleonardo theccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells AT broekhuizenrichard theccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells AT leisewitzandrea theccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells AT nervibruno theccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells AT ramirezpabloa theccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells AT macanaspirardpatricia ccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells AT quezadathomas ccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells AT navarreteleonardo ccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells AT broekhuizenrichard ccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells AT leisewitzandrea ccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells AT nervibruno ccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells AT ramirezpabloa ccl2ccr2axisaffectstransmigrationandproliferationbutnotresistancetochemotherapyofacutemyeloidleukemiacells |